BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35073182)

  • 1. Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumors.
    Baliga S; Matsui J; Klamer B; Cetnar A; Ewing A; Cadieux C; Gupta A; Setty BA; Roberts RD; Olshefski RS; Cripe TP; Scharschmidt TJ; Aldrink J; Mardis E; Yeager ND; Palmer JD
    Br J Radiol; 2022 May; 95(1133):20211088. PubMed ID: 35073182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiotherapy for distant metastases to the head and neck.
    Mutsaers A; Abugharib A; Poon I; Loblaw J; Bayley A; Zhang L; Chin L; Galapin M; Erler D; Sahgal A; Higgins K; Enepekides D; Eskander A; Karam I
    Support Care Cancer; 2024 Mar; 32(4):230. PubMed ID: 38488881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
    Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
    Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
    Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma.
    Parsai S; Sedor G; Smile TD; Scott J; Ochocki A; Vassil N; Zahler S; Angelov L; Chao ST; Qi P; Anderson P; Murphy ES
    Am J Clin Oncol; 2021 Mar; 44(3):126-130. PubMed ID: 33405479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Body Radiation Therapy for Metastatic and Recurrent Solid Tumors in Children and Young Adults.
    Tinkle CL; Singh C; Lloyd S; Guo Y; Li Y; Pappo AS; DuBois SG; Lucas JT; Haas-Kogan DA; Terezakis SA; Braunstein SE; Krasin MJ
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1396-1405. PubMed ID: 33259934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases.
    Sogono P; Bressel M; David S; Shaw M; Chander S; Chu J; Plumridge N; Byrne K; Hardcastle N; Kron T; Wheeler G; Hanna GG; MacManus M; Ball D; Siva S
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):756-763. PubMed ID: 33069796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiation therapy (SBRT) in recurrent, persistent or oligometastatic gynecological cancers.
    Reshko LB; Baliga S; Crandley EF; Harry Lomas IV; Richardson MK; Spencer K; Bennion N; Mikdachi HE; Irvin W; Kersh CR
    Gynecol Oncol; 2020 Dec; 159(3):611-617. PubMed ID: 33059914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Shahi J; Poon I; Ung YC; Tsao M; Bjarnason GA; Malik NH; Zhang L; Louie AV; Cheung P
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):764-774. PubMed ID: 33115687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients.
    Collen C; Christian N; Schallier D; Meysman M; Duchateau M; Storme G; De Ridder M
    Ann Oncol; 2014 Oct; 25(10):1954-1959. PubMed ID: 25114022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of stereotactic magnetic resonance image-guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis.
    Yoon SM; Luterstein E; Chu FI; Cao M; Lamb J; Agazaryan N; Low D; Raldow A; Steinberg ML; Lee P
    Cancer Med; 2021 Sep; 10(17):5897-5906. PubMed ID: 34288538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy.
    Davis JN; Medbery C; Sharma S; Danish A; Mahadevan A
    Radiat Oncol; 2013 Nov; 8():275. PubMed ID: 24274599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy for adrenal oligometastasis in lung cancer patients.
    Arcidiacono F; Aristei C; Marchionni A; Italiani M; Fulcheri CPL; Saldi S; Casale M; Ingrosso G; Anselmo P; Maranzano E
    Br J Radiol; 2020 Nov; 93(1115):20200645. PubMed ID: 32822540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases.
    Yeung R; Hamm J; Liu M; Schellenberg D
    Radiat Oncol; 2017 Jun; 12(1):105. PubMed ID: 28637480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer.
    Ouyang W; Yu J; Nuerjiang S; Li Z; Wang D; Wang X; Zhang J; Xie C
    Cancer Med; 2019 Aug; 8(10):4605-4614. PubMed ID: 31245933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease.
    Ramadan S; Quan K; Schnarr K; Juergens RA; Hotte SJ; Mukherjee SD; Kapoor A; Meyers BM; Swaminath A
    Acta Oncol; 2022 Jun; 61(6):705-713. PubMed ID: 35435129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy for recurrent and oligometastatic soft tissue sarcoma.
    Feng XY; Li J; Li AM; Jing SH; Zhu XX; Wang Z
    World J Surg Oncol; 2022 Sep; 20(1):322. PubMed ID: 36171617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-institutional phase 2 trial of stereotactic body radiotherapy in the treatment of bone metastases in pediatric and young adult patients with sarcoma.
    Elledge CR; Krasin MJ; Ladra MM; Alcorn SR; Han P; Gibbs IC; Hiniker SM; Laack NN; Terezakis SA
    Cancer; 2021 Mar; 127(5):739-747. PubMed ID: 33170960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local Control Outcomes Using Stereotactic Body Radiation Therapy or Surgical Resection for Metastatic Sarcoma.
    Gutkin PM; von Eyben R; Chin A; Donaldson SS; Oh J; Jiang A; Ganjoo KN; Avedian RS; Bruzoni M; Steffner RJ; Moding EJ; Hiniker SM
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):771-779. PubMed ID: 35643255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.
    Macchia G; Lazzari R; Colombo N; Laliscia C; Capelli G; D'Agostino GR; Deodato F; Maranzano E; Ippolito E; Ronchi S; Paiar F; Scorsetti M; Cilla S; Ingargiola R; Huscher A; Cerrotta AM; Fodor A; Vicenzi L; Russo D; Borghesi S; Perrucci E; Pignata S; Aristei C; Morganti AG; Scambia G; Valentini V; Jereczek-Fossa BA; Ferrandina G
    Oncologist; 2020 Feb; 25(2):e311-e320. PubMed ID: 32043791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.